This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Discussion on Comorbidity in Social Anxiety Disorder: Impact on Disease Burden and Management

Published: May 21, 1998

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Dr. Ballenger: You made one incredibly important point. The research is clear that general practitioners recognize any and all psychiatric problems 10 times more frequently
if the patient comes in and talks about a psychological problem. Comorbidity also results in increased recognition of psychiatric problems and more appropriate
treatment.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Anxiety

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...